[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "AS TMT REQUIRES sample DJ PROTEOMICS VK ALL DTT SN QY RAW disease BRENDA MOD BTO MS:1001251 PS HCD age alkylation reagent TO NOT VCF THE reduction reagent individual PEPTIDESEQ LI cleavage agent details PSI characteristics SH HF HANCESTRO JA TA ANY disease stage MAGE COULD URI FDR PATO CT developmental stage OF PO WILL label ROW sex ENVO MIAME spiked compound PATCH TAB II RFC MS RECOMMENDED INFORMATION III XML DDA CL CV CLO NOTE THAT ISA HTML ... organism part source name BE depletion NCE file your TIP PRM MAY IMPORTANT DISCLAIMS RIGHTS SDRF MHC SP LC MAJOR MUST XL proteomics data acquisition method DOID UBERON CN EBI PARTICULAR AC MERCHANTABILITY HEREIN PRIDE OR IMPLIED INFRINGE data file fractionation method MC IS IDF COLUMN INCLUDING USE FITNESS SHOULD README HUPO CELL collision energy PP MONDO NCBI PRIDE:0000659 NT SILAC LIMITED pooled sample MINOR STANDARDS ID SHALL fraction identifier mass PMCID EW MT dissociation method BMC organism FOR DIA REQUIRED source name_ and _assay name SWATH BUT INITIATIVE EXPRESS CF EM RECOMMEND CS URL ancestry category EFO technical replicate PMID cell type instrument biological replicate exclamation CPTAC biosample accession number PTM WARRANTIES replicate SRM IAA WARRANTY OPTIONAL PURPOSE ZFA CID"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "AS TMT REQUIRES DJ PROTEOMICS VK ALL DTT SN QY RAW disease BRENDA MOD BTO MS:1001251 PS HCD age alkylation reagent TO NOT VCF THE reduction reagent individual PEPTIDESEQ LI cleavage agent details PSI SH HF HANCESTRO JA TA ANY disease stage MAGE COULD URI FDR PATO CT OF PO WILL label ROW sex ENVO MIAME spiked compound PATCH TAB II RFC MS RECOMMENDED INFORMATION III DDA CL CV CLO THAT ISA HTML ... organism part BE depletion NCE PRM MAY DISCLAIMS RIGHTS SDRF MHC SP LC MAJOR MUST XL proteomics data acquisition method DOID UBERON CN EBI PARTICULAR AC MERCHANTABILITY HEREIN PRIDE OR IMPLIED INFRINGE data file fractionation method MC IS IDF COLUMN INCLUDING USE FITNESS SHOULD README HUPO CELL collision energy PP MONDO NCBI PRIDE:0000659 NT SILAC LIMITED pooled sample MINOR STANDARDS SHALL fraction identifier mass PMCID EW MT dissociation method BMC organism FOR DIA REQUIRED SWATH BUT INITIATIVE EXPRESS CF EM RECOMMEND CS URL ancestry category EFO technical replicate PMID cell type instrument biological replicate CPTAC biosample accession number PTM WARRANTIES SRM IAA WARRANTY OPTIONAL PURPOSE ZFA CID"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "COVID UBERON:0000178 CL:0000235 MONDO:0100096 MONDO:0005180 ALL disease UBERON:0000948 CL:0000623 age UBERON:0001969 individual UBERON:0001977 CL:0000787 HANCESTRO CL:0000813 CL:0000066 CL:0000232 UBERON:0001155 PATO:0000461 NK PATO developmental stage PO sex CL:0000233 UBERON:0001359 CL NOTE MONDO:0008383 organism part source name depletion TIP MAY IMPORTANT UBERON:0002113 CL:0000788 synthetic peptide CL:0000057 SDRF PDX MONDO:0005575 UBERON:0000310 MUST MONDO:0005148 CL:0000084 DOID UBERON CL:0000182 CL:0000624 compound xenograft CL:0000625 DSS SHOULD CL:0000236 CL:0000898 MONDO NCBI CL:0000540 MONDO:0004975 MONDO:0005301 NSG CL:0000913 lib disease model MONDO:0005105 UBERON:0002048 ID enrichment process UBERON:0002097 CSF MONDO:0005138 APP organism PATO:0000383 CML UBERON:0000955 MONDO:0004989 URL ancestry category EFO cell type PATO:0001340 UBERON:0001088 biological replicate MONDO:0004946 exclamation PTM PATO:0000384 CL:0000576 CL:0000815 UBERON:0002107 CL:0000451"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "COVID UBERON:0000178 CL:0000235 MONDO:0100096 MONDO:0005180 ALL disease UBERON:0000948 CL:0000623 age UBERON:0001969 individual UBERON:0001977 CL:0000787 HANCESTRO CL:0000813 CL:0000066 CL:0000232 UBERON:0001155 PATO:0000461 NK PATO developmental stage PO sex CL:0000233 UBERON:0001359 CL MONDO:0008383 organism part source name depletion MAY synthetic peptide UBERON:0002113 CL:0000788 CL:0000057 SDRF PDX MONDO:0005575 UBERON:0000310 MUST MONDO:0005148 CL:0000084 DOID UBERON CL:0000182 CL:0000624 compound xenograft CL:0000625 DSS SHOULD CL:0000236 CL:0000898 MONDO NCBI CL:0000540 MONDO:0004975 MONDO:0005301 NSG CL:0000913 disease model MONDO:0005105 UBERON:0002048 ID enrichment process UBERON:0002097 CSF MONDO:0005138 APP organism PATO:0000383 CML UBERON:0000955 MONDO:0004989 URL ancestry category EFO cell type PATO:0001340 UBERON:0001088 biological replicate MONDO:0004946 PTM PATO:0000384 CL:0000576 CL:0000815 UBERON:0002107 CL:0000451"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C71732 HANCESTRO:0009 PREFERRED pre-existing condition NCIT:C81328 medication history NCIT:C28079 disease NCIT:C53553 secondary condition NCIT:C65108 NCIT:C81327 age NCIT:C15262 treatment individual NCI NCIT:C15313 treatment status diet GDPR BMI HANCESTRO NCIT:C4870 NCIT:C16358 disease stage NCIT:C15632 NCIT:C14167 dose NCIT:C27966 sex ER NCIT:C65107 MONDO:0004995 II PD tumor grade NCIT:C53554 TNM staging III UO NOTE MONDO:0005044 CHEBI:41774 HANCESTRO:0006 ethnicity organism part NCIT:C28076 IMPORTANT time post treatment NCIT:C27971 SDRF NCIT:C27970 prior treatment NCIT:C18206 MONDO:0005148 sampling time point HANCESTRO:0010 AJCC compound alcohol consumption MONDO:0011122 MONDO:0002050 NCIT:C15329 IV breast cancer subtype NCIT:C14169 HIPAA NCIT:C62723 NCIT:C28078 menopausal status MONDO NCIT:C14174 gestational age PR NCIT:C18213 NCIT:C28054 CHEBI:28748 NCIT:C18058 TNM NCIT:C28077 ID NCIT MONDO:0005300 weight organism NCIT:C15445 height ACE NCIT:C68804 body mass index treatment response HANCESTRO:0005 MONDO:0004979 Dukes stage ancestry category EFO NCIT:C14168 CHEBI:27899 NCIT:C53555 smoking status exclamation Ann Arbor stage pregnancy status NCIT:C53556 CHEBI:6801 NCIT:C65106"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C71732 HANCESTRO:0009 PREFERRED pre-existing condition NCIT:C81328 medication history NCIT:C28079 disease NCIT:C53553 secondary condition NCIT:C65108 NCIT:C81327 age NCIT:C15262 treatment individual NCI NCIT:C15313 treatment status diet GDPR BMI HANCESTRO NCIT:C4870 NCIT:C16358 disease stage NCIT:C15632 NCIT:C14167 dose NCIT:C27966 sex ER NCIT:C65107 MONDO:0004995 II PD tumor grade NCIT:C53554 TNM staging III UO MONDO:0005044 CHEBI:41774 HANCESTRO:0006 ethnicity organism part NCIT:C28076 time post treatment NCIT:C27971 SDRF NCIT:C27970 prior treatment NCIT:C18206 MONDO:0005148 sampling time point HANCESTRO:0010 AJCC compound alcohol consumption MONDO:0011122 MONDO:0002050 NCIT:C15329 IV breast cancer subtype NCIT:C14169 HIPAA NCIT:C62723 NCIT:C28078 menopausal status MONDO NCIT:C14174 gestational age PR NCIT:C18213 NCIT:C28054 CHEBI:28748 NCIT:C18058 TNM NCIT:C28077 ID NCIT MONDO:0005300 weight organism NCIT:C15445 height ACE NCIT:C68804 body mass index treatment response HANCESTRO:0005 MONDO:0004979 Dukes stage ancestry category EFO NCIT:C14168 CHEBI:27899 NCIT:C53555 smoking status Ann Arbor stage pregnancy status NCIT:C53556 CHEBI:6801 NCIT:C65106"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "TMT label UNIMOD:4 ID fragment mass tolerance sample fraction MS:1001917 fraction identifier UNIMOD:35 AC TS RAW precursor mass tolerance MT MS:1001306 MS2 analyzer type MS:1001309 PRIDE cleavage agent details MS RECOMMENDED TOF data file scan window lower limit MOD LTQ MS:1001251 DIA RPPA DDA REQUIRED UNIMOD:21 proteomics data acquisition method NOTE MS:1001313 proteomexchange accession number PRIDE:0000663 MGF SHOULD UNIMOD:1 CF file uri TIP PRM MSD ST CS PSI PP ELISA IMPORTANT KR URL FTP technical replicate instrument exclamation SCIEX HF MM MS1 scan range SDRF MRM TA MS:1001303 SRM NT SILAC UNIMOD scan window upper limit modification parameters URI MUST XL UNIMOD:737"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "TMT label UNIMOD:4 ID fragment mass tolerance MS:1001917 fraction identifier UNIMOD:35 AC TS RAW precursor mass tolerance MT MS:1001306 MS2 analyzer type MS:1001309 PRIDE MS RECOMMENDED TOF data file scan window lower limit MOD LTQ MS:1001251 DIA RPPA DDA REQUIRED UNIMOD:21 proteomics data acquisition method proteomexchange accession number MS:1001313 PRIDE:0000663 MGF SHOULD UNIMOD:1 CF file uri PRM MSD ST CS PSI PP ELISA KR URL FTP technical replicate cleavage agent details instrument SCIEX HF MM MS1 scan range SDRF MRM TA MS:1001303 SRM NT SILAC UNIMOD scan window upper limit modification parameters URI MUST XL UNIMOD:737"
  }
]